GEVO Form 144: Christopher Ryan sells 217,497 shares

GEVO reported Form 144 notices for sales of Common Stock by Christopher Ryan.

Rhea-AI Filing Summary

GEVO reported Form 144 notices for sales of Common Stock by Christopher Ryan. The filing lists three dispositions: 100,000 shares sold on 03/30/2026 for $275,740, 29,797 shares sold on 03/31/2026 for $88,175, and 87,700 shares sold on 05/27/2026 for $154,334. The filing also lists a Restricted Stock Awards entry showing 70,028 shares with an associated date of 06/12/2026 under equity compensation.

Insights

Securities Compliance Analyst

Form 144 discloses routine insider dispositions by Christopher Ryan.

The filings list three completed sales with exact share counts and dollar amounts: $275,740 for 100,000 shares on 03/30/2026, $88,175 for 29,797 shares on 03/31/2026, and $154,334 for 87,700 shares on 05/27/2026. These items are presented as Rule 144 dispositions and include a separate equity compensation line showing 70,028 Restricted Stock Awards dated 06/12/2026.

Cash‑flow treatment and whether sales were pursuant to a trading plan are not stated in the excerpt; subsequent filings or broker records would show execution method. Future filings may clarify the relationship between the restricted award line and the reported sales.

Key Figures

Shares sold (03/30/2026): 100,000 shares Proceeds (03/30/2026): $275,740 Shares sold (03/31/2026): 29,797 shares +4 more

7 metrics

Shares sold (03/30/2026) 100,000 shares sale on 03/30/2026

Proceeds (03/30/2026) $275,740 sale proceeds reported for 100,000 shares

Shares sold (03/31/2026) 29,797 shares sale on 03/31/2026

Proceeds (03/31/2026) $88,175 sale proceeds reported for 29,797 shares

Shares sold (05/27/2026) 87,700 shares sale on 05/27/2026

Proceeds (05/27/2026) $154,334 sale proceeds reported for 87,700 shares

Restricted Stock Awards listed 70,028 shares entry dated 06/12/2026 under equity compensation

Key Terms

Rule 144, Restricted Stock Awards, Equity Compensation

3 terms

Rule 144 regulatory

"144: Securities Sold During The Past 3 Months"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Awards financial

"Common Stock | 06/09/2025 | Restricted Stock Awards | Issuer"

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

Equity Compensation financial

"06/12/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What sales does the GEVO Form 144 report show for Christopher Ryan?

The filing reports three sales: 100,000 shares on 03/30/2026 for $275,740, 29,797 shares on 03/31/2026 for $88,175, and 87,700 shares on 05/27/2026 for $154,334. These figures appear verbatim in the excerpt.

Does the Form 144 show any equity awards for GEVO related to these transactions?

The excerpt lists a Restricted Stock Awards entry of 70,028 shares dated 06/12/2026 under equity compensation. The filing text does not state how that award relates to the reported sales.

Are the proceeds recipients or use of proceeds specified in the filing?

The filing provides gross dollar amounts for each sale ($275,740, $88,175, $154,334) but does not disclose who received the proceeds or any use of proceeds in the provided excerpt.

Does the Form 144 indicate these sales were made under a trading plan or Rule 10b5-1?

The provided excerpt does not state whether the sales were made under a trading plan or Rule 10b5-1. The filing lists dates, share counts, and amounts but does not include trading‑plan language in the visible text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 04:59 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001512143
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Gevo, Inc.
SEC File Number	001-35073
Address of Issuer	345 INVERNESS DRIVE SOUTH, BUILDING C Suite 310 ENGLEWOOD COLORADO 80112
Phone	303-858-8358
Name of Person for Whose Account the Securities are To Be Sold	Ryan Christopher Michael
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	35196	50161.34	243411329	06/12/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/09/2025	Restricted Stock Awards	Issuer			70028	06/12/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christopher Ryan 345 INVERNESS DR. SOUTH BUILDING C SUITE 310 ENGLEWOOD CO 80112	Common Stock	03/30/2026	100000	275740.00
Christopher Ryan 345 INVERNESS DR. SOUTH BUILDING C, SUITE 310 ENGLEWOOD CO 80112	Common Stock	03/31/2026	29797	88175.00
Christopher Ryan 345 INVERNESS DR. SOUTH BUILDING C SUITE 310 ENGLEWOOD CO 80112	Common Stock	05/27/2026	87700	154334.00

144: Remarks and Signature

Remarks
Date of Notice	06/12/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Weimer, as a duly authorized representative of STIFEL, as attorney-in-fact for Christopher Ryan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)